Setting 
My Cart

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Toggle Nav
mobile icon
Close
  • Menu
  • Setting
  • Home
  • Search results for: 'pi3 kinase p110'

Search results for: 'pi3 kinase p110'

Items 1-10 of 13

Page
per page
  1. PP 1
    A8215 PP 1
    Target: Src|EGFR|JAK|ZAP-70
    Summary: Src family tyrosine kinase inhibitor
  2. TAK-901
    A4124 TAK-901
    Target: Aurora Kinases|FLT3|Src|JAK|LRRK2|Hck|FGR|YES|Fyn|ARG
    Summary: Novel Aurora A/B inhibitor
      ≥25.25 mg/mL
  3. Tofacitinib (CP-690550,Tasocitinib)
    A4138 Tofacitinib (CP-690550,Tasocitinib)
     1 Citation
    Target: JAK
    Summary: Janus kinase inhibitor
      insoluble in EtOH; insoluble in H2O; ≥15.6 mg/mL
  4. AG-490
    A4139 AG-490
     3 Citation
    Target: EGFR|JAK
    Summary: JAK2/EGFR inhibitor
      insoluble in H2O; ≥14.7 mg/mL
  5. TG101348 (SAR302503)
    A4136 TG101348 (SAR302503)
     2 Citation
    Target: FLT3|JAK|c-RET
    Summary: JAK-2 inhibitor,potent and selective
      ≥26.23 mg/mL
  6. Cercosporamide
    A4511 Cercosporamide
    Target: JAK|MNK
    Summary: Mnk2 and JAK3 inhibitor
      soluble in DMSO
  7. Tofacitinib (CP-690550) Citrate
    A4135 Tofacitinib (CP-690550) Citrate
     2 Citation
    Target: JAK
    Summary: Potent JAK inhibitor
      ≥25.22 mg/mL
  8. WP1066
    A4140 WP1066
    Target: STAT|JAK
    Summary: JAK2/STAT3 inhibitor,cell-permeable
      insoluble in H2O; ≥17.8 mg/mL
  9. Ruxolitinib (INCB018424)
    A3012 Ruxolitinib (INCB018424)
     4 Citation
    Target: JAK
    Summary: JAK inhibitor
      insoluble in H2O; ≥15.32 mg/mL
  10. S-Ruxolitinib (INCB018424)
    A4149 S-Ruxolitinib (INCB018424)
    Target: JAK
    Summary: JAK1/2 inhibitor,potent and selective
      Soluble in DMSO

Items 1-10 of 13

Page
per page